Volume 7, Issue 1 (2026)                   J Clinic Care Skill 2026, 7(1): 15-20 | Back to browse issues page
Article Type:
Original Research |
Subject:

Print XML PDF HTML Full-Text (HTML)


History

How to cite this article
Mohammadhoseini A, Momtahan E, Mansourian A. Propofol vs. Dexmedetomidine Sedation in Post-Cholecystectomy Patients. J Clinic Care Skill 2026; 7 (1) :15-20
URL: http://jccs.yums.ac.ir/article-1-464-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
1- “Department of Anesthesiology, Faculty of Medicine” and “Clinical Research Development Unit Shahid Jalil”, Yasuj University of Medical Science, Yasuj, Iran
2- Student Research Committee, Yasuj University of Medical Science, Yasuj, Iran
* Corresponding Author Address: Faculty of Medicine, Yasuj University of Medical Sciences, Shahid Gurban Ali Jalil Street, Yasuj, Iran. Postal Code: 7591994799 (afshin.mansourian@yahoo.com)
Abstract   (766 Views)
Aims: Propofol and dexmedetomidine are used for general anesthesia. This study aimed to compare the effects of propofol and dexmedetomidine infusion on sedation in the recovery room for patients undergoing cholecystectomy.
Materials & Methods: This randomized clinical trial was conducted on 70 patients scheduled for laparoscopic cholecystectomy in Yasuj between 2023 and 2024. Patients were randomly assigned to two groups, including 35 cases who received propofol and 35 cases who received dexmedetomidine. The level of agitation was assessed using the Richmond Agitation-Sedation Scale at 0 and 40 minutes after surgery by the researcher. Data analysis was performed using SPSS 27 software utilizing the Chi-square test, independent t-test, and paired t-test. A significance level of p<0.05 was considered.
Findings: At 40 minutes after the intervention, the mean agitation level in patients receiving dexmedetomidine (0.22±0.72) was significantly lower than that of the propofol group (0.63±0.81), indicating better sedation (p=0.028).
Conclusion: Dexmedetomidine is a preferable option than propofol for anesthesia management in patients undergoing laparoscopic cholecystectomy.
Keywords:

References
1. Antoniou SA, Antoniou GA, Antoniou AI, Granderath FA. Past, present, and future of minimally invasive abdominal surgery. JSLS. 2015;19(3):e2015.00052. [Link] [DOI:10.4293/JSLS.2015.00052]
2. Oti C, Mahendran M, Sabir N. Anaesthesia for laparoscopic surgery. Br J Hosp Med. 2016;77(1):24-8. [Link] [DOI:10.12968/hmed.2016.77.1.24]
3. Ghomeishi A, Mohtadi AR, Behaeen K, Nesioonpour S, Bakhtiari N, Khalvati Fahlyani F. Comparison of the effect of propofol and dexmedetomidine on hemodynamic parameters and stress response hormones during laparoscopic cholecystectomy surgery. Anesthesiol Pain Med. 2021;11(5):e119446. [Link] [DOI:10.5812/aapm.119446]
4. Giri SK, Mohapatra PS, Senapati LK, Mishra K. A comparison of hemodynamic changes between the use of etomidate and propofol as induction agents for anesthesia in daycare surgeries. Cureus. 2022;14(12):e32421. [Link] [DOI:10.7759/cureus.32421]
5. Salerno J, Jones J, Jones M, Plate C, Lewis D. Long-term detection of propofol glucuronide in urine following anesthetic induction and maintenance with propofol. Pharmacol Pharm. 2013;4(7):528. [Link] [DOI:10.4236/pp.2013.47076]
6. Condello I, Santarpino G, Fiore F, Di Bari N, Speziale G, Moscarelli M, et al. Propofol pharmacokinetics and pharmacodynamics-a perspective in minimally invasive extracorporeal circulation. Interact Cardiovasc Thorac Surg. 2021;33(4):625-7. [Link] [DOI:10.1093/icvts/ivab143]
7. Yu S, Liao J, Lin X, Luo Y, Lu G. Crucial role of autophagy in propofol-treated neurological diseases: A comprehensive review. Front Cell Neurosci. 2023;17:1274727. [Link] [DOI:10.3389/fncel.2023.1274727]
8. Li S, Lei Z, Zhao M, Hou Y, Wang D, Xu X, et al. Propofol inhibits ischemia/reperfusion-induced cardiotoxicity through the protein kinase C/nuclear factor erythroid 2-related factor pathway. Front Pharmacol. 2021;12:655726. [Link] [DOI:10.3389/fphar.2021.655726]
9. Isik B, Arslan M, Özsoylar Ö, Akçabay M. The effects of α2-adrenergic receptor agonist dexmedetomidine on hemodynamic response in direct laryngoscopy. Open Otorhinolaryngol J. 2007;1(1):5-11. [Link] [DOI:10.2174/1874428100701010005]
10. Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, Young WL. Miller's anesthesia e-book. Amsterdam: Elsevier Health Sciences; 2014. [Link]
11. Chilkoti GT, Karthik G, Rautela R. Evaluation of postoperative analgesic efficacy and perioperative hemodynamic changes with low dose intravenous dexmedetomidine infusion in patients undergoing laparoscopic cholecystectomy-A randomised, double-blinded, placebo-controlled trial. J Anaesthesiol Clin Pharmacol. 2020;36(1):72-7. [Link] [DOI:10.4103/joacp.JOACP_184_17]
12. Tanya S, Mahima L, Vinod K, Anshul G, Suveer S. A comparative study to see the effect of different dexmedetomidine infusion doses on the hemodynamic stress response, sedation and post-operative analgesia in patients undergoing laparoscopic cholecystectomy. J Pharm Negat Results. 2022;13(6):166-73. [Link]
13. Rolaniya SL, Dhawan S, Kumari M, Jain R, Pareek A, Sehtia S. Comparison of conventional dose and low dose infusion of dexmedetomidine on hemodynamic stress response, dose of induction agent and postoperative analgesia in patients undergoing laparoscopic cholecystectomy. Int Arch Integr Med. 2017;4(7):111-7. [Link]
14. Ihmsen H, Saari TI. Dexmedetomidine. Pharmacokinetics and pharmacodynamics. Anaesthesist. 2012;61(12):1059-66. [German] [Link] [DOI:10.1007/s00101-012-2114-1]
15. Tosh P, Rajan S, Narayani N, Babu KC, Kumar N, Paul J. Comparison of efficacy and safety of dexmedetomidine versus propofol infusion for maintaining depth of general anesthesia when muscle relaxants are not used. Bali J Anesthesiol. 2020;4(2):42-5. [Link] [DOI:10.4103/BJOA.BJOA_6_20]
16. Janatmakan F, Nassajian N, Jarirahmadi S, Tabatabaee K, Zafari M. Comparison of the effect of dexmedetomidine and remifentanil on pain control after spinal surgery: A double-blind, randomized clinical trial. Anesthesiol Pain Med. 2021;11(2):e111533. [Link] [DOI:10.5812/aapm.111533]
17. Tang C, Xia Z. Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic. J Pain Res. 2017;10:1899-904. [Link] [DOI:10.2147/JPR.S139387]
18. Giovannitti Jr JA, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: A review of current clinical applications. Anesth Prog. 2015;62(1):31-9. [Link] [DOI:10.2344/0003-3006-62.1.31]
19. Yang A, Gao F. Effect of dexmedetomidine combined with propofol on stress response, hemodynamics, and postoperative complications in patients undergoing laparoscopic cholecystectomy. Am J Transl Res. 2021;13(10):11824-32. [Link]
20. Verma R, Nadeem A, Bafila NS, Gautam SD, Kumar D, Giri MK, et al. A comparative analysis of dexmedetomidine infusion rates on hemodynamic responses during laparoscopic cholecystectomy: An observational study. Cureus. 2024;16(11):e74538. [Link] [DOI:10.7759/cureus.74538]
21. Srivastava VK, Nagle V, Agrawal S, Kumar D, Verma A, Kedia S. Comparative evaluation of dexmedetomidine and esmolol on hemodynamic responses during laparoscopic cholecystectomy. J Clin Diagn Res. 2015;9(3):Uc01-5. [Link] [DOI:10.7860/JCDR/2015/11607.5674]
22. Dongare D, Gharde S. Effects of dexmedetomidine on intraoperative hemodynamic responses in patients undergoing laparoscopic cholecystectomy: A randomised double blind trial. Arch Anesthesiol Crit Care. 2021;7(4):227-33. [Link] [DOI:10.18502/aacc.v7i4.7629]
23. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: Reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983-91. [Link] [DOI:10.1001/jama.289.22.2983]
24. Tadrisi SD, Madani SJ, Farmand F, Ebadi A, Karimi Zarchi AA, Saghafinia M, et al. Richmond agitation-sedation scale validity and reliability in intensive care unit adult patients; Persian version. Crit Care Nurs. 2009;2(1):15-21. [Persian] [Link]
25. Kaur M, Singh PM. Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res. 2011;5(2):128-33. [Link] [DOI:10.4103/0259-1162.94750]
26. Zhou H, Xie Z, Brambrink AM, Yang G. Behavioural impairments after exposure of neonatal mice to propofol are accompanied by reductions in neuronal activity in cortical circuitry. Br J Anaesth. 2021;126(6):1141-56. [Link] [DOI:10.1016/j.bja.2021.01.017]
27. Bhutia MP, Rai A. Attenuation of haemodynamic parameters in response to pneumoperitoneum during laparoscopic cholecystectomy: A randomized controlled trial comparing infusions of propofol and dexmedetomidine. J Clin Diagn Res. 2017;11(5):UC01-4. [Link] [DOI:10.7860/JCDR/2017/26239.9810]
28. Alinaghimaddah SM, Akbari MR, Tabrizi KK, Ownagh V, Hatami SE. Comparison of the effects of midazolam, propofol, and dexmedetomidine on hemodynamic variation in patients undergoing cataract surgery under local anesthesia at 5th Azar Hospital in Gorgan in 2021-2022. J North Khorasan Univ Med Sci. 2023;14(4):47-54. [Persian] [Link] [DOI:10.32592/nkums.14.4.47]
29. Louie JM, Lonardo NW, Mone MC, Stevens VW, Deka R, Shipley W, et al. Outcomes when using adjunct dexmedetomidine with propofol sedation in mechanically ventilated surgical intensive care patients. Pharmacy. 2018;6(3):93. [Link] [DOI:10.3390/pharmacy6030093]
30. Djaiani G, Silverton N, Fedorko L, Carroll J, Styra R, Rao V, et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery. Anesthesiology. 2016;124(2):362-8. [Link] [DOI:10.1097/ALN.0000000000000951]
31. Shah PN, Dongre V, Patil V, Pandya S, Mungantiwar A, Choulwar A. Comparison of post-operative ICU sedation between dexmedetomidine and propofol in Indian population. Indian J Crit Care Med. 2014;18(5):291-6. [Link] [DOI:10.4103/0972-5229.132485]